Alcon AG | ALC - Gross Profit On Sales

Stock Price
59.46
Daily Change
-0.44 -0.73%
Monthly
-7.50%
Yearly
-26.39%
Q1 Forecast
59.31

Alcon AG reported $1.52B in Gross Profit on Sales for its fiscal quarter ending in December of 2025.





Gross Profit On Sales Change Date
AstraZeneca USD 12.39B 5M Dec/2025
Bayer EUR 5.35B 1.02B Sep/2025
Essilor EUR 8.3B 547M Dec/2025
Fresenius EUR 1.51B 214M Dec/2025
Fresenius Medical Care EUR 1.39B 147M Dec/2025
GlaxoSmithKline GBP 6.18B 106M Dec/2025
GRIFOLS EUR 743.8M 49.13M Jun/2025
Lonza CHF 1.29B 248M Jun/2025
Merck EUR 2.96B 252M Dec/2025
Novartis USD 10.82B 695M Sep/2025
Philips EUR 2.29B 377M Dec/2025
Roche Holding CHF 22.09B 10.04B Dec/2025
Sanofi EUR 8.45B 1.31B Dec/2025
Smith & Nephew USD 2.09B 117M Dec/2025
Sonova Holding CHF 1.28B 205.2M Dec/2025
UCB EUR 2.46B 520M Dec/2024